Healthcare

Each two new shares will come with one free attaching option, with up to 179,329,495 options to be issued. The options will have an exercise price of A$0.006 and will expire on 30 June 2029, with each option convertible into one ordinary share. The …

On 29 September 2026, Firebrick announced its decision to actively enter the US retail pharmacy market with Nasodine products. The move followed growth in online sales and the company’s attendance in August at the National Association of Chain Drug Stores retail trade expo in …

Field sales teams have completed training on both tests, including their intended clinical uses and how clinicians and patients can access them. Proteomics International and Healius have also agreed joint sales and marketing plans to build clinician awareness, provide education and support appropriate referrals.

On 21 October 2026, CSL Limited (ASX:CSL) announced the appointment of Deborah Waterhouse as chief executive officer and managing director from 1 February 2027, following a global search. She has more than 25 years of experience managing specialty pharmaceutical businesses across several international markets.

Acrux Limited (ASX:ACR) is a specialty pharmaceutical company that develops and commercialises topically applied products, with licensees marketing its products worldwide and a particular emphasis on the United States. Its quarterly activities report and Appendix 4C for the June 2026 quarter, lodged on 31 …

Noxopharm (ASX:NOX) is an Australian clinical-stage company built around Sofra, its proprietary platform of synthetic nucleic acids (oligonucleotides) designed to mimic the body's natural immune regulators. Its lead candidate, SOF-SKN, is a topical therapy aimed at autoimmune skin disease. ASX announcements dated 14 September …

Nova Eye Medical Limited (ASX:EYE) announced on 23 October 2026 that Mr Mike Southard has resigned as a director of the company, ending eight years of service on the Board. The company, a medical technology business focused on advanced ophthalmic treatment technologies and devices, …